Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Oct 29, 2026

Jake McCarley, Co-Founder and CEO of Alluvium, highlights how chatbots have evolved from simple question-and-answer functions to actively helping patients navigate complex health systems. The Alluvium platform integrates existing EMR systems with real-time information to provide intelligent patient support,...


Oct 29, 2026

Jake McCarley, Co-Founder and CEO of Alluvium, highlights how chatbots have evolved from simple question-and-answer functions to actively helping patients navigate complex health systems. The Alluvium platform integrates existing EMR systems with real-time information to provide intelligent patient support,...


Oct 29, 2026

Dr. Christopher Moertel, Global Head of Clinical Development at Healx, describes how AI is transforming the discovery and development of treatments for rare diseases. Healx is using computational chemistry and AI to match disease pathways with existing compounds to identify drugs that may be repurposed or combined for...


Oct 29, 2026

Dr. Christopher Moertel, Global Head of Clinical Development at Healx, describes how AI is transforming the discovery and development of treatments for rare diseases. Healx is using computational chemistry and AI to match disease pathways with existing compounds to identify drugs that may be repurposed or combined for...


Oct 28, 2026

Dr. Aneel Nimba, Medical Director at Faron Pharmaceuticals,  discusses the company's innovative approach to treating higher risk myelodysplastic syndromes, a group of rare blood cancers, with its lead drug candidate that targets the CLEVER-1 receptor which controls the tumor microenvironment. This first-in-class...